Clinical evaluation of the effect on oral administration of peenisa chooranam in the management of sinusitis
Phase 2
Completed
- Conditions
- Health Condition 1: J01- Acute sinusitis
- Registration Number
- CTRI/2020/12/029756
- Lead Sponsor
- Magendiran S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Nasal congestion
2.purulent and watery discharge
3.cough and sneezing
Exclusion Criteria
1.severe and recurrent epistaxis due to sinusitis
2.TB rhinitis
3.Rhinosporidiasis
4.Malignancy related sinusitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reducing nasal congestion,purulent and watery nasal discharge,pain and tenderness around the nose,orbit and maxillary region,cough and sneezingTimepoint: 1 week
- Secondary Outcome Measures
Name Time Method Assessed by SNOT-22Timepoint: 2 weeks